Anika Therapeutics. has been granted a patent for an apparatus designed for microfracture procedures. The device features a tapered cannula and a movable penetrator, enabling the formation of microfractures in subchondral bone to promote cartilage regeneration without rotating the penetrator during the process. GlobalData’s report on Anika Therapeutics gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Anika Therapeutics, was a key innovation area identified from patents. Anika Therapeutics's grant share as of June 2024 was 56%. Grant share is based on the ratio of number of grants to total number of patents.
Apparatus for microfracture to promote cartilage regeneration
The patent US12016574B2 describes an innovative apparatus designed for medical applications, specifically for creating microfractures in subchondral bone. The apparatus consists of a cannula with a tapered channel that transitions from a larger first transverse dimension at the first end to a smaller second transverse dimension at the second end. This design allows for a penetrator, which can be moved between a retracted and an extended position, to extend beyond the cannula's second end without rotation. The penetrator is engineered to create a microfracture with a depth of at least 5 mm, facilitating targeted treatment in orthopedic procedures.
Further details of the apparatus include a primary portion and a distal portion of the cannula, with the distal portion featuring curved segments and a channel that accommodates the penetrator. The penetrator itself has a pointed tip and a circular cross-section that narrows towards the distal end, enhancing its ability to penetrate bone effectively. The design also incorporates a penetrator removal tab for easy retraction and a coating on the penetrator for improved performance. The apparatus is intended for manual operation, ensuring that medical professionals can utilize it efficiently in clinical settings.
To know more about GlobalData’s detailed insights on Anika Therapeutics, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
